miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression
Authors:
Open Access
- 6 July 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (30) , 48547-48561
Abstract
MiR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-B and sustains NF-B activation by decreasing Cylindromatosis expressionKeywords
This publication has 43 references indexed in Scilit:
- TGF-β induces miR-182 to sustain NF-κB activation in glioma subsetsJournal of Clinical Investigation, 2012
- Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axisOncogene, 2012
- Celebrating 25 years of NF‐κB researchImmunological Reviews, 2012
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort studyBMJ Open, 2012
- Deubiquitinases in the regulation of NF-κB signalingCell Research, 2010
- Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer developmentOncogene, 2010
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- NF-κB and cancer — identifying targets and mechanismsCurrent Opinion in Genetics & Development, 2008
- A ubiquitin ligase complex assembles linear polyubiquitin chainsThe EMBO Journal, 2006
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999